Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety, pharmacokinetics and pharmacodynamics study of CHF 5074 in healthy young male subjects; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• CHF 5074

Snippet

Sponsor: CERESPIR | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED